In addition, mutations and abnormal expression of EGFR have been observed in different cancer types, including glioblastomas, non-small cell lung cancer (NSCLC), breast cancer, and ovarian cancer [33,34,35,36]. This evidence concerns the gene EGFR and breast carcinoma.